Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Bell

Surgery Caldwell, ID Doctor of Osteopathy

NPI 1942463799 CMS profile 360458

315 E Elm St Ste 350, Caldwell, ID 83605

Open in the dashboard

General payments

$9,788

72 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adam Bell of Caldwell, ID is reported in the CMS Open Payments database as having received $9,788 across 72 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $234 6
2024 General $275 9
2023 General $1,114 12
2022 General $1,387 16
2021 General $3,346 10
2020 General $574 8
2019 General $2,859 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Bell
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Adam Bell were reported at $234. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Adam Bell Surgery median Middle half National median
2019 $2,859 $253 $82–$1,521 $163
2020 $574 $131 $40–$706 $114
2021 $3,346 $168 $50–$904 $132
2022 $1,387 $224 $76–$1,218 $149
2023 $1,114 $253 $82–$1,255 $160
2024 $275 $279 $90–$1,381 $164
2025 $234 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $7,608 33 payments
  2. Stryker Corporation $1,334 12 payments
  3. TELA Bio, Inc. $405 12 payments
  4. CooperSurgical, Inc. $141 2 payments
  5. Innovation Technologies Inc $45 1 payment
  6. Ethicon US, LLC $40 2 payments
  7. AstraZeneca Pharmaceuticals LP $40 2 payments
  8. Myriad Genetic Laboratories, Inc. $32 1 payment
  9. Sawtooth Surgical Solutions Inc $31 1 payment
  10. W. L. Gore & Associates, Inc. $25 1 payment
  11. Other $88 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $4,000 2 payments
  2. Travel and Lodging $3,600 15 payments
  3. Food and Beverage $2,171 54 payments
  4. Gift $17 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System Surgery $4,608 32 payments
  2. Da Vinci Surgical System Surgery $3,000 1 payment
  3. SPY-PHI SYSTEM $1,251 11 payments
  4. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $255 9 payments
  5. OviTex 2S $150 3 payments
  6. SDC3 $83 1 payment
  7. ONETRAC LX $72 1 payment
  8. INSORB $69 1 payment
  9. Irrisept $45 1 payment
  10. myRisk $32 1 payment
  11. Other $183 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

36

Median for General Surgery: 59

Drug cost

$63

Median for General Surgery: $393

Branded share of claims

100%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 36 $63

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$37,459

Medicare's payments for the services billed

Medicare patients

111

Average age 73

Services billed

251

52 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 42%
Chronic kidney disease 35%
Diabetes 30%
Ischemic heart disease 27%
Atrial fibrillation 23%
Cancer 21%
Depression 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ENHERTU
  • Daiichi Sankyo Inc. $24
$24 — —
AMVUTTRA
  • Alnylam Pharmaceuticals Inc. $14
$14 — —
TREMFYA
  • Janssen Biotech, Inc. $4
$4 — —
SIMPONI
  • Janssen Biotech, Inc. $4
$4 — —
SIMPONI ARIA
  • Janssen Biotech, Inc. $4
$4 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

72 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record